Lactylation drives tumor progression and immune evasion in triple negative breast cancer
Breast cancer maintains its position as the most prevalent malignancy in women worldwide, with triple-negative breast cancer (TNBC)…
It’s almost flu season. Should you still get a shot, and will insurance cover it?
For parents of school-aged children, the fall to-do list can seem ever-growing. Buy school supplies. Fill out endless…
Stem-like peripheral helper T cells found to sustain inflammation in rheumatoid arthritis
Rheumatoid arthritis (RA) is an autoimmune disease that affects millions worldwide and can have a devastating impact on…
Wealthy countries pay more for essential medicines, but the cost burden is far lower, study finds
Published on 17/08/2025 – 9:30 GMT+2 ADVERTISEMENT Wealthy countries may pay steep prices for medicines, but once their…
In Oregon and Beyond, Many Kids in Mental Health Crises Come to the ER—And Languish
A few years ago, the Portland-based health policy researcher John McConnell recalls, he started hearing about a problem.…
Dual epigenetic marks found to regulate cell identity
Shedding light on what determines how cells become what they are meant to be-nerves, bone, muscles, etc.-can also…
Triglycerides identified as direct cause of abdominal aortic aneurysms
High levels of triglycerides, the most common type of fat in the body and the foods we eat,…
PSMA PET/CT improves outcomes for men with recurrent prostate cancer
A new study from Denmark shows for the first time that men with biochemically recurrent prostate cancer who…
HonorHealth taps longevity authority Nicholas J. Schork to lead new research division
Nicholas J. Schork, Ph.D., an international authority on human longevity and health maintenance, has joined HonorHealth Research Institute…
Study identifies a promising new strategy for treating alcohol use disorder
Researchers have identified a promising new strategy for treating alcohol use disorder (AUD). A novel study found that…
New drug-releasing system eliminates tumors in 82% of high-risk bladder cancer patients
A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for…
OU researchers explore how cannabis use affects recovery after head and neck cancer surgery
University of Oklahoma researchers are conducting a first-of-its-kind study to determine whether cannabis use affects recovery from the…